Cover Image
市場調查報告書

全球止血分析設備市場趨勢,機器分析,市場佔有率預測

Global Hemostasis Analyzers Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 384991
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球止血分析設備市場趨勢,機器分析,市場佔有率預測 Global Hemostasis Analyzers Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022
出版日期: 2016年11月05日 內容資訊: 英文 140 Pages
簡介

本報告提供全球止血分析設備市場相關調查,各市場區隔趨勢,競爭趨勢,各地區趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介

  • 摘要整理
  • 市場範圍

第2章 市場概要

  • 發展和變遷
  • 產業結構
  • 製造流程
  • 相關法規
  • 市場分析
  • 預測分析
  • 策略分析
  • 競爭分析
  • 策略性建議和結論

第3章 市場決策因素

  • 推動市場的要素與市場的影響
  • 阻礙市場的要素與市場的影響
  • 市場機會
  • 市場課題

第4章 市場區隔

  • 各產品
  • 各檢驗類型
  • 各技術
  • 各終端用戶

第5章 競爭環境

  • 主要策略
  • 10家大企業分析

第6章 各地區市場

  • 支持決策的資料庫與預測方法
  • 市場區隔的比較分析
  • 機會矩陣
  • 各地區市場區隔
    • 北美
    • 歐洲
    • 亞太地區
    • 其他各國

第7章 企業簡介

  • ALERE INC.
  • BECKMAN COULTER
  • BECTON DICKINSON
  • DIAGNOSTICA STAGO INC.
  • HELENA LABORATORIES
  • 株式會社堀場製作所
  • INSTRUMENTATION LABORATORY WERFEN GROUP
  • INTERNATIONAL TECHNIDYNE CORPORATION
  • MINDRAY
  • 日本光電工業株式會社
  • ROCHE DIAGNOSTICS
  • SIEMENS HEALTHCARE
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • TRANSASIA BIO MEDICAL LTD.

圖表

目錄
Product Code: HME-3991116

Hemostasis is the study of the methods involved in blood clotting (coagulation). Hematology analyzers, also known as coagulation analyzers, are devices supporting in treatment of patients with bleeding disorders; those with substitution heart valves and patients who are at high risk of bleeding during surgical procedures. Growing demand for fast and exact results is the driving force for companies to build up new system capabilities and modern technologies in their hematology analyzers. The global Hemostasis analyzers market is projected to growabout US$ 4500 million with a CAGR of 9.7 % during 2016-2022. A number of factors such as the expansion of high-throughput hemostasis analyzers, growing acceptance of automated hemostasis instruments by diagnostic laboratories, advancements in technology and developments of high sensitivity point-of-care hemostasis testing are pushing the growth of the global hemostasis analyzers market. The biggest challenge for the vendors is the need to focus on customer concerns and demands along with instruments provision with higher effectiveness, throughput, accuracy and improved productivity at lower cost.

Segmentation of the global hemostasis analyzers market is done into product type, type of test, technology, and user and geography. Segmentation by product type is done on the basis of clinical laboratory analyzers, consumables, and hemostasis analyzers point-of-care testing. Hemostasis analyzers sub segment of clinical laboratory analyzers is projected to observe attractive growth in the future years owing to rising demand for automated hemostasis analyzers in health diagnosis. On the basis of test type market is segmented into D dimer testing kits, fibrinogen testing kits prothrombin time testing kits, activated clotting time testing kits, and other testing kits. On the basis of technology market is segmented into optical, electrochemical, mechanical and other technology. Mechanical hemostasis analyzers are projected to observe considerable growth in the market share, largely due to sophisticated, accurate and efficient management at a lower cost. In end user market is segmented into diagnostic laboratories, research institutes, standalone hospitals and other end users. Due to the implementation of latest technology and heavy budgetary spending the medical and research institutes are expected to witness favorable growth over the forecast period.

Segmentation by geographically of the global hemostasis analyzers market is done into Asia Pacific, Europe, North America and RoW. North America region dominates the global hematology analyzers market due to the growing installed device base leading to higher support services and sales of reagents in the United States. Beckman Coulter is the market leader for hematology analyzers in the US, though company faces constant competition from Sysmex products. Rising markets of China, India and Brazil are registering significant growth due to growing population level, large healthcare expenditure by government, financial growth and improving technical abilities by these countries.

Key players operating in hemostasis analyzer market are, Alere Inc., Helena Laboratories, Horiba, Mindray, Nihon Kohden Corporation (Nihon Kohden), Roche Diagnostics, Siemens Healthcare, Sysmex Corporation and Thermo Fisher Scientific, Inc. etc. Merger & acquisitions, new product development, technological collaborations, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. MARKET SCOPE

2. MARKET OVERVIEW

  • 2.1. GLOBAL HEMOSTASIS ANALYZER MARKET : EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. MANUFACTURING PROCESS
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
    • 2.6.1. R & D INVESTMENT IN HEMOSTASIS ANALYZER
    • 2.6.2. DEMAND OF HEMOSTASIS ANALYZER ACROSS END USER INDUSTRIES
    • 2.6.3. REVENUE OF TOP 5 MARKET PLAYERS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. PRICING ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    • 2.7.7. ROI ANALYSIS
    • 2.7.8. GAP ANALYSIS
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES AND ANALYSIS
    • 2.8.2. MARKET SHARE
    • 2.8.3. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS & MARKET IMPACT
    • 3.1.1. INCREASING ADOPTION OF AUTOMATED HEMOSTASIS INSTRUMENTS BY DIAGNOSTIC LABORATORIES
    • 3.1.2. FOCUS OF KEY PLAYERS ON THE DEVELOPMENT OF TECHNOLOGICALLY ADVANCED HEMOSTASIS ANALYZER
    • 3.1.3. DEVELOPMENT OF HIGH THROUGHPUT HEMOSTASIS ANALYZERS
    • 3.1.4. LARGE NUMBER OF AWARENESS CAMPAIGNS/ CONFERENCES IN DEVELOPING COUNTRIES
    • 3.1.5. DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) HEMOSTASIS TESTING
  • 3.2. MARKET RESTRAINTS & MARKET IMPACT
    • 3.2.1. HIGH COST OF FULLY AUTOMATED HEMOSTASIS ANALYZERS
    • 3.2.2. SLOW ADOPTION OF ADVANCED HEMOSTASIS INSTRUMENTS IN DEVELOPING COUNTRIES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWING INCLINATION TOWARDS POINT-OF-CARE (POC) HEMOSTASIS ANALYZERS
    • 3.3.2. RAPID GROWTH OF HEMOSTASIS MARKET IN EMERGING COUNTRIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. CONCERN FOR HIGHER THROUGHPUT AND ENHANCED PRODUCTIVITY AT LOWER COST.
    • 3.4.2. STANDARDS FOR INSTRUMENTS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL HEMOSTASIS ANALYZER MARKET BY PRODUCT TYPE 2014-2022 ($ MILLION)
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. CLINICAL LABORATORY ANALYZERS 2014-2022 ($ MILLION)
        • 4.1.5.1.1. APPLICATIONS
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.1.5.1.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
          • 4.1.5.1.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 4.1.5.1.3.3. PRICE ANALYSIS
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. CONSUMABLES ANALYZER 2014-2022 ($ MILLION)
        • 4.1.5.2.1. APPLICATIONS
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.1.5.2.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
          • 4.1.5.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 4.1.5.2.3.3. PRICE ANALYSIS
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
      • 4.1.5.3. POINT-OF-CARE TESTING 2014-2022 ($ MILLION)
        • 4.1.5.3.1. APPLICATIONS
        • 4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.1.5.3.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
          • 4.1.5.3.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 4.1.5.3.3.3. PRICE ANALYSIS
        • 4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.5. KEY CONCLUSIONS
  • 4.2. GLOBAL HEMOSTASIS ANALYZER MARKET BY TEST TYPE 2014-2022 ($ MILLION)
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. PROTHROMBIN TIME (PT/INR) TESTING KITS 2014-2022 ($ MILLION)
        • 4.2.5.1.1. APPLICATIONS
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.2.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS 2014-2022 ($ MILLION)
        • 4.2.5.2.1. APPLICATIONS
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.2.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. D DIMER TESTING KITS 2014-2022 ($ MILLION)
        • 4.2.5.3.1. APPLICATIONS
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.2.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
      • 4.2.5.4. FIBRINOGEN TESTING KITS 2014-2022 ($ MILLION)
        • 4.2.5.4.1. APPLICATIONS
        • 4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.2.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.4.5. KEY CONCLUSIONS
      • 4.2.5.5. OTHERS TESTING KITS TESTING KITS 2014-2022 ($ MILLION)
        • 4.2.5.5.1. APPLICATIONS
        • 4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.2.5.5.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.5.5. KEY CONCLUSIONS
  • 4.3. GLOBAL HEMOSTASIS ANALYZER MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. MECHANICAL TECHNOLOGIES 2014-2022 ($ MILLION)
        • 4.3.5.1.1. APPLICATIONS
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.3.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. OPTICAL TECHNOLOGIES 2014-2022 ($ MILLION)
        • 4.3.5.2.1. APPLICATIONS
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.3.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. ELECTROCHEMICAL TECHNOLOGIES 2014-2022 ($ MILLION)
        • 4.3.5.3.1. APPLICATIONS
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.3.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS
      • 4.3.5.4. OTHERS TECHNOLOGIES 2014-2022 ($ MILLION)
        • 4.3.5.4.1. APPLICATIONS
        • 4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.3.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.4.5. KEY CONCLUSIONS
  • 4.4. GLOBAL HEMOSTASIS ANALYZER MARKET BY END USER 2014-2022 ($ MILLION)
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. RESEARCH INSTITUTES 2014-2022 ($ MILLION)
        • 4.4.5.1.1. APPLICATIONS
        • 4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.4.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.1.5. KEY CONCLUSIONS
      • 4.4.5.2. DIAGNOSTIC LABORATORIES 2014-2022 ($ MILLION)
        • 4.4.5.2.1. APPLICATIONS
        • 4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.4.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.2.5. KEY CONCLUSIONS
      • 4.4.5.3. STANDALONE HOSPITALS 2014-2022 ($ MILLION)
        • 4.4.5.3.1. APPLICATIONS
        • 4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.4.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.3.5. KEY CONCLUSIONS
      • 4.4.5.4. OTHER END USERS 2014-2022 ($ MILLION)
        • 4.4.5.4.1. APPLICATIONS
        • 4.4.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 4.4.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
        • 4.4.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.4.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS - DASHBOARD

6. GLOBAL HEMOSTASIS ANALYZER MARKET BY REGION (REVENUE ANALYSIS), 2014-2022 ($ MILLION)

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GEOGRAPHIC SEGMENTATION
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.1.2.1.3. PRICE ANALYSIS
          • 6.4.1.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.5. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.1.2.2.3. PRICE ANALYSIS
          • 6.4.1.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.5. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.1.3. PRICE ANALYSIS
          • 6.4.2.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.5. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.2.3. PRICE ANALYSIS
          • 6.4.2.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.5. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.3.3. PRICE ANALYSIS
          • 6.4.2.2.3.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.5. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.4.3. PRICE ANALYSIS
          • 6.4.2.2.4.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.5. KEY CONCLUSIONS
        • 6.4.2.2.5. ITALY
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.5.3. PRICE ANALYSIS
          • 6.4.2.2.5.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.5. KEY CONCLUSIONS
        • 6.4.2.2.6. REST OF EUROPE
          • 6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.6.3. PRICE ANALYSIS
          • 6.4.2.2.6.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.6.5. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.1.3. PRICE ANALYSIS
          • 6.4.3.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.5. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.2.3. PRICE ANALYSIS
          • 6.4.3.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.5. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.3.3. PRICE ANALYSIS
          • 6.4.3.2.3.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.5. KEY CONCLUSIONS
        • 6.4.3.2.4. SOUTH KOREA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.4.3. PRICE ANALYSIS
          • 6.4.3.2.4.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.5. KEY CONCLUSIONS
        • 6.4.3.2.5. AUSTRALIA
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.5.3. PRICE ANALYSIS
          • 6.4.3.2.5.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.5. KEY CONCLUSIONS
        • 6.4.3.2.6. REST OF ASIA PACIFIC
          • 6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.6.3. PRICE ANALYSIS
          • 6.4.3.2.6.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.6.5. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.1.3. PRICE ANALYSIS
          • 6.4.4.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.5. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.2.3. PRICE ANALYSIS
          • 6.4.4.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.5. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ALERE INC.
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
  • 7.2. BECKMAN COULTER
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
  • 7.3. BECTON DICKINSON
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
  • 7.4. DIAGNOSTICA STAGO INC.
    • 7.4.1. . OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
  • 7.5. HELENA LABORATORIES
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. HORIBA
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
  • 7.7. INSTRUMENTATION LABORATORY WERFEN GROUP
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
  • 7.8. INTERNATIONAL TECHNIDYNE CORPORATION
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
  • 7.9. MINDRAY
    • 7.9.1. . OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
  • 7.10. NIHON KOHDEN CORPORATION (NIHON KOHDEN)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
  • 7.11. ROCHE DIAGNOSTICS
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6.
  • 7.12. SIEMENS HEALTHCARE
    • 7.12.1. . OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
  • 7.13. SYSMEX CORPORATION
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
  • 7.14. THERMO FISHER SCIENTIFIC, INC.
    • 7.14.1. . OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
  • 7.15. TRANSASIA BIO MEDICAL LTD.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS

LIST OF TABLES

  • TABLE 1. GLOBAL HEMOSTASIS ANALYZER MARKET BY PRODUCT TYPE 2014-2022 ($ MILLION)
  • TABLE 2. GLOBAL HEMOSTASIS CLINICAL LABORATORY ANALYZERS MARKET BY GEOGRAPHY 2014 - 2022 ($ MILLION)
  • TABLE 3. GLOBAL HEMOSTASIS ANALYZER CONSUMABLES MARKET BY GEOGRAPHY 2014 - 2022 ($ MILLION)
  • TABLE 4. GLOBAL HEMOSTASIS ANALYZER FOR POINT-OF-CARE TESTING MARKET BY GEOGRAPHY 2014 - 2022 ($ MILLION)
  • TABLE 5. GLOBAL HEMOSTASIS ANALYZER MARKET BY TEST TYPE 2014-2022 ($ MILLION)
  • TABLE 6. GLOBAL HEMOSTASIS ANALYZER PROTHROMBIN TIME (PT/INR) TESTING KITS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 7. GLOBAL HEMOSTASIS ANALYZER ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 8. GLOBAL HEMOSTASIS ANALYZER D DIMER TESTING KITS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 9. GLOBAL HEMOSTASIS ANALYZER FIBRINOGEN TESTING KITS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 10. GLOBAL HEMOSTASIS ANALYZER OTHERS TESTING KITS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 11. GLOBAL HEMOSTASIS ANALYZER MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
  • TABLE 12. GLOBAL HEMOSTASIS ANALYZER MECHANICAL MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 13. GLOBAL HEMOSTASIS ANALYZER OPTICAL MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 14. GLOBAL HEMOSTASIS ANALYZER ELECTROCHEMICAL MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 15. GLOBAL HEMOSTASIS ANALYZER OTHERS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 16. GLOBAL HEMOSTASIS ANALYZER MARKET BY END USER 2014-2022 ($ MILLION)
  • TABLE 17. GLOBAL HEMOSTASIS ANALYZER RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 18. GLOBAL HEMOSTASIS ANALYZER DIAGNOSTIC LABORATORIES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 19. GLOBAL HEMOSTASIS ANALYZER STANDALONE HOSPITALS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 20. GLOBAL HEMOSTASIS ANALYZER OTHER END USERS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 21. NORTH AMERICA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • TABLE 22. EUROPE HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • TABLE 23. ASIA PACIFIC HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • TABLE 24. REST OF THE WORLD HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMOSTASIS ANALYZER CLINICAL LABORATORY ANALYZERS MARKET 2014 - 2022 ($ MILLION)
  • FIGURE 2. GLOBAL HEMOSTASIS ANALYZER CONSUMABLES MARKET 2014 - 2022 ($ MILLION)
  • FIGURE 3. GLOBAL HEMOSTASIS ANALYZER FOR POINT-OF-CARE TESTING MARKET 2014 - 2022 ($ MILLION)
  • FIGURE 4. GLOBAL HEMOSTASIS ANALYZER PROTHROMBIN TIME (PT/INR) TESTING KITS MARKET 2014-2022 ($ MILLION)
  • FIGURE 5. GLOBAL HEMOSTASIS ANALYZER ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS MARKET 2014-2022 ($ MILLION)
  • FIGURE 6. GLOBAL HEMOSTASIS ANALYZER D DIMER TESTING KITS MARKET 2014-2022 ($ MILLION)
  • FIGURE 7. GLOBAL HEMOSTASIS ANALYZER FIBRINOGEN TESTING KITS MARKET 2014-2022 ($ MILLION)
  • FIGURE 8. GLOBAL HEMOSTASIS ANALYZER OTHERS TESTING KITS MARKET 2014-2022 ($ MILLION)
  • FIGURE 9. GLOBAL HEMOSTASIS ANALYZER MECHANICAL MARKET 2014-2022 ($ MILLION)
  • FIGURE 10. GLOBAL HEMOSTASIS ANALYZER OPTICAL MARKET 2014-2022 ($ MILLION)
  • FIGURE 11. GLOBAL HEMOSTASIS ANALYZER ELECTROCHEMICAL MARKET 2014-2022 ($ MILLION)
  • FIGURE 12. GLOBAL HEMOSTASIS ANALYZER OTHERS MARKET 2014-2022 ($ MILLION)
  • FIGURE 13. GLOBAL HEMOSTASIS ANALYZER RESEARCH INSTITUTES MARKET 2014-2022 ($ MILLION)
  • FIGURE 14. GLOBAL HEMOSTASIS ANALYZER DIAGNOSTIC LABORATORIES MARKET 2014-2022 ($ MILLION)
  • FIGURE 15. GLOBAL HEMOSTASIS ANALYZER STANDALONE HOSPITALS MARKET 2014-2022 ($ MILLION)
  • FIGURE 16. GLOBAL HEMOSTASIS ANALYZER OTHER END USERS MARKET 2014-2022 ($ MILLION)
  • FIGURE 17. NORTH AMERICA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 18. UNITED STATES (U.S.) HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 19. CANADA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION))
  • FIGURE 20. EUROPE HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 21. UNITED KINGDOM (UK) HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 22. FRANCE HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 23. GERMANY HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 24. SPAIN HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 25. ITALY HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 26. ROE HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 27. ASIA PACIFIC HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 28. INDIA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 29. CHINA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 30. JAPAN HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 31. KOREA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 32. AUSTRALIA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 33. ROAPAC HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 34. REST OF THE WORLD HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 35. LATIN AMERICA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 36. MENA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
  • FIGURE 37. AFRICA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)
Back to Top